1. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol;Vogelpoel;J Pharm Sci,2004
2. World Health Organization (WHO).2006.Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms. Technical Report Series, No 937, 40th Report, Annex 8 of WHO Expert Committee on Specifications for Pharmaceutical Preparations. Available from:http://whqlibdoc.who.int/trs/WHO_TRS_937_eng.pdf. Accessed Date: May 20, 2009.
3. U.S., Department of Health and Human Services, Food and Drug Administration, Center for Evaluation and Research (CDER).2000.Guidances for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. Available from:http://www.fda.gov/CDER/GUIDANCE/3618fnl.pdf. Accessed Date: May 20, 2009.
4. European Medicines Evaluation Agency (EMEA), Committee for Proprietary Medicinal Products (CPMP).2001.Note for Guidance on the Investigation of Bioavailability and Bioequivalence. Available from:http://www.emea.eu.int/pdfs/human/ewp/140198en.pdf. Accessed Date: May 20, 2009.
5. Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol);Kalantzi;J Pharm Sci,2006